Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

2,624 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Toxicity of irinotecan (CPT-11) and hepato-renal dysfunction.
Ong SY, Clarke SJ, Bishop J, Dodds HM, Rivory LP. Ong SY, et al. Anticancer Drugs. 2001 Aug;12(7):619-25. doi: 10.1097/00001813-200108000-00009. Anticancer Drugs. 2001. PMID: 11487719
Trace analysis of SN-38 in human plasma by high-performance liquid chromatography.
Rivory LP, Findlay M, Clarke S, Bishop J. Rivory LP, et al. J Chromatogr B Biomed Sci Appl. 1998 Sep 4;714(2):355-9. doi: 10.1016/s0378-4347(98)00216-3. J Chromatogr B Biomed Sci Appl. 1998. PMID: 9766876
A phase III study of radiotherapy with and without continuous-infusion fluorouracil as palliation for non-small-cell lung cancer.
Ball D, Smith J, Bishop J, Olver I, Davis S, O'Brien P, Bernshaw D, Ryan G, Millward M. Ball D, et al. Br J Cancer. 1997;75(5):690-7. doi: 10.1038/bjc.1997.123. Br J Cancer. 1997. PMID: 9043026 Free PMC article. Clinical Trial.
Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.
Zalcberg J, Millward M, Bishop J, McKeage M, Zimet A, Toner G, Friedlander M, Barter C, Rischin D, Loret C, James R, Bougan N, Berille J. Zalcberg J, et al. J Clin Oncol. 1998 May;16(5):1948-53. doi: 10.1200/JCO.1998.16.5.1948. J Clin Oncol. 1998. PMID: 9586914 Clinical Trial.
A phase II trial of zeniplatin in metastatic melanoma.
Olver I, Green M, Peters W, Zimet A, Toner G, Bishop J, Ketelbey W, Rastogi R, Birkhofer M. Olver I, et al. Am J Clin Oncol. 1995 Feb;18(1):56-8. doi: 10.1097/00000421-199502000-00012. Am J Clin Oncol. 1995. PMID: 7847260 Clinical Trial.
Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer.
Bishop J, Murray R, Webster L, Pitt P, Stokes K, Fennessy A, Olver I, Leber G. Bishop J, et al. Cancer Chemother Pharmacol. 1992;30(3):174-8. doi: 10.1007/BF00686307. Cancer Chemother Pharmacol. 1992. PMID: 1385761 Clinical Trial.
Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.
Millward MJ, Zalcberg J, Bishop JF, Webster LK, Zimet A, Rischin D, Toner GC, Laird J, Cosolo W, Urch M, Bruno R, Loret C, James R, Blanc C. Millward MJ, et al. J Clin Oncol. 1997 Feb;15(2):750-8. doi: 10.1200/JCO.1997.15.2.750. J Clin Oncol. 1997. PMID: 9053501 Clinical Trial.
Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.
Millward MJ, Boyer MJ, Lehnert M, Clarke S, Rischin D, Goh BC, Wong J, McNeil E, Bishop JF. Millward MJ, et al. Ann Oncol. 2003 Mar;14(3):449-54. doi: 10.1093/annonc/mdg118. Ann Oncol. 2003. PMID: 12598352 Clinical Trial.
Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer.
Bishop JF, Dewar J, Toner GC, Smith J, Tattersall MH, Olver IN, Ackland S, Kennedy I, Goldstein D, Gurney H, Walpole E, Levi J, Stephenson J, Canetta R. Bishop JF, et al. J Clin Oncol. 1999 Aug;17(8):2355-64. doi: 10.1200/JCO.1999.17.8.2355. J Clin Oncol. 1999. PMID: 10561297 Clinical Trial.
2,624 results
Jump to page
Feedback